Global ConSeptS – Consultancy
Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
How will Sustainability and Transformation Plans (STPs) change the NHS in 2017?
White Papers and Resources | February 9, 2017 | Wilmington Healthcare
Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the impact that STPs will have on the NHS and what this means for pharma.
Is fear an effective driver of behaviour change?
White Papers and Resources | February 1, 2017 | Blue Latitude Health
Client Lead Natalie Seebeck explains that applying fear-based models in communications can be effective, if the right components are used in the right way.
PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS
Press Releases | January 31, 2017 | Inizio
Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed...
2017 Trends Reports
White Papers and Resources | January 27, 2017 | Syneos Health®
GSW and InVentiv Health Communications are pleased to release the 6th installment of the Trends report series, consisting of four reports: Consumer, Digital, Communications and Healthcare
Smart connections with a human touch
White Papers and Resources | January 26, 2017 | Blue Latitude Health
Simon Young, Director at Blue Latitude Health, discusses how advances in technology are influencing the future of the expert-patient relationship and why healthcare businesses must evaluate how best to support...
AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH
White Papers and Resources | January 25, 2017 | Syneos Health®
Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care.
Mental Health Patient Advocacy Groups in EU Say Strong Partnerships with Government and Industry Can Ensure Forward Progress
Press Releases | January 25, 2017 | Syneos Health®
New Report from inVentiv Health Examines Mental Health Advocacy Wish Lists and Priorities for Reform
Cool heads in a crisis?
White Papers and Resources | January 25, 2017 | Inizio
Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics
Biosimilars: Bringing patients into the conversation
White Papers and Resources | January 25, 2017 | Inizio
Published in eyeforpharma January 2017 by Mariel Metcalfe
Access and elimination: the future of DAAs in hepatitis C
White Papers and Resources | January 25, 2017 | Inizio
Published in Pharmaphorum January 2017